Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials recruiting in Michigan

Fewer than 3 recruiting trials found.

All Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials nationally

1

Recruiting in Michigan

1

Cities with sites

Cities in Michigan

Troy 1

Recruiting trials in Michigan

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Michigan: Troy

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.